Soleus Capital Management’s CalciMedica CALC Stock Holding History

Soleus Capital Management’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-683,904	Closed	-$4.51M	–	97
2025 Q4	$4.51M	Hold	683,904	–	–	0.17%	69
2025 Q3	$2.1M	Sell	683,904 -100,000	-13%	-$288K	0.11%	74
2025 Q2	$1.25M	Hold	783,904	–	–	0.08%	82
2025 Q1	$1.5M	Hold	783,904	–	–	0.11%	68
2024 Q4	$2.78M	Hold	783,904	–	–	0.17%	63
2024 Q3	$3.47M	Hold	783,904	–	–	0.27%	70
2024 Q2	$3.1M	Hold	783,904	–	–	0.27%	70
2024 Q1	$3.26M	Buy	+783,904	New	+$3.58M	0.24%	70

Other funds holding CALC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Soleus Capital Management's CALC Position: Q1 2026 in Review

Soleus Capital Management sold out of CalciMedica (CALC) in Q1 2026, closing a stake of 683,904 shares — an estimated $4.51M sold.

Soleus Capital Management first reported a position in CALC in Q1 2024 and held it in 8 quarters. The position peaked at $4.51M in Q4 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

Soleus Capital Management reported no remaining CalciMedica position as of Q1 2026 after selling out during the quarter.
Soleus Capital Management sold 683,904 CalciMedica shares in Q1 2026, an estimated $4.51M.
Soleus Capital Management first reported a position in CalciMedica in Q1 2024 and held it in 8 quarters.
Soleus Capital Management's CalciMedica position peaked at $4.51M in Q4 2025.
27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.